Atlas Trials

A Study to Evaluate the Effectiveness of Intravitreal Aflibercept in Patients With Diabetic Macular Edema and/or Macular Edema Secondary to Retinal Vein Occlusion, Which Either Have or Have Not Been Pretreated for Their Disease

Clinical trial NCT03161912 · COMPLETED

Trial details

NCT number
NCT03161912
Sponsor
Bayer
Status
COMPLETED
Study type
OBSERVATIONAL
Macular Edema
Start date
2017-11-24
Primary completion
2021-09-14
Enrollment
2481

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.